secwatch.observer — SEC 8-K summary
======================================

Issuer:     Axe Compute Inc. (AGPU)
CIK:        0001446159
Form:       8-K
Filed at:   2025-04-01T23:59:59+00:00
Accession:  0001171843-25-001901
Event type: earnings
Sentiment:  negative
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Predictive Oncology FY2024 loss $10.8M on $1.6M revenue; cash drops to $0.7M; merger with Renovaro pending
--------------------------------------------------------------------------------

- Revenue of $1.6M essentially flat YoY; loss from continuing ops of $10.8M.
- Cash and equivalents fell to $734,673 from $8.7M; stockholder deficit of ($202,610).
- Net loss per share from continuing ops improved 33% to $1.99.
- Raised $3M in early 2025 via asset sale, warrant exercises, and Renovaro financing.
- Still working toward definitive merger agreement with Renovaro after Jan LOI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325001901/0001171843-25-001901-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1446159/000117184325001901/f8k_033125.htm
  HTML page:      https://secwatch.observer/filing/0001171843-25-001901

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer